Antitumor Immunity Augmented by Combining Radiofrequency Ablation with Anti–CTLA-4 Therapy in a Subcutaneous Murine Hepatoma Model
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (7) , 1178-1186
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Anticancer Association EYAS Project (SACA-CY1C17)
This publication has 32 references indexed in Scilit:
- Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced CancersFrontiers in Oncology, 2018
- Thermal Ablative Therapies and Immune Checkpoint Modulation: Can Locoregional Approaches Effect a Systemic Response?Gastroenterology Research and Practice, 2016
- More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of CancerJournal of Immunology Research, 2011
- Principles of and Advances in Percutaneous AblationRadiology, 2011
- Percutaneous Ablation of Hepatocellular Carcinoma: Current StatusJournal of Vascular and Interventional Radiology, 2010
- Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablationEuropean Radiology, 2009
- Radiofrequency Thermal Ablation of Hepatocellular Carcinoma Liver Nodules Can Activate and Enhance Tumor-Specific T-Cell ResponsesCancer Research, 2006
- Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastasesWorld Journal of Gastroenterology, 2006
- The use of radiofrequency in cancerBritish Journal of Cancer, 2005
- In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor ImmunityCancer Research, 2004